Latest Safety News

Page 150 of 166
AdAlta Limited is accelerating its 'East to West' cellular immunotherapy strategy, aiming to bridge Asian innovation with Western clinical development and manufacturing to target solid cancers. The company plans to secure three assets by the end of 2025 and initiate clinical trials, positioning itself as a leader in this emerging market.
Ada Torres
Ada Torres
7 Feb 2025
Actinogen Medical has published a peer-reviewed article confirming the efficacy of a 10 mg daily dose of Xanamem for treating neurological conditions, reinforcing its ongoing clinical trials in Alzheimer's and depression.
Ada Torres
Ada Torres
6 Feb 2025
Lindian Resources has awarded a $1.3 million contract to Mota-Engil for the construction of a critical access road at its Kangankunde Rare Earths Project in Malawi, marking a key milestone in project development and local infrastructure enhancement.
Maxwell Dee
Maxwell Dee
6 Feb 2025
WA Kaolin Limited has announced a fully underwritten pro-rata accelerated non-renounceable rights offer to raise approximately $7 million, aiming to bolster working capital and support production ramp-up at its Wickepin operations.
Maxwell Dee
Maxwell Dee
6 Feb 2025
WA Kaolin Ltd has launched a fully underwritten A$7 million entitlement offer to fund a critical ramp-up in production following successful operational upgrades. With strong forward orders and supportive major shareholders, the company aims to achieve positive cash flow and expand its market footprint.
Maxwell Dee
Maxwell Dee
6 Feb 2025
WA Kaolin Limited is raising A$7 million through a fully underwritten entitlement offer to support its sales ramp-up and working capital needs, following a successful upgrade to its classifier project that enhances production capabilities.
Maxwell Dee
Maxwell Dee
6 Feb 2025
AdAlta has fast-tracked its cellular immunotherapy growth by signing two new term sheets for clinical-stage CAR-T products from Asia, pivoting to focus on in-licensing and clinical trials while winding down internal R&D on its antifibrotic drug AD-214.
Ada Torres
Ada Torres
6 Feb 2025
Beach Energy has reported a robust first half of FY25, marked by a 37% increase in underlying earnings and significant progress on key projects including the Waitsia Gas Plant commissioning and Moomba CCS. The company’s strong operational performance supports a 50% increase in its interim dividend.
Maxwell Dee
Maxwell Dee
6 Feb 2025
Beach Energy has reported a robust 15% increase in production and a 37% rise in underlying NPAT for the first half of FY25, underpinned by operational improvements and strategic initiatives. The company also announced a 50% increase in its interim dividend, signaling strong confidence in its financial outlook.
Maxwell Dee
Maxwell Dee
6 Feb 2025
A new peer-reviewed study highlights Cynata Therapeutics’ Cymerus™ iPSC-derived MSCs as superior to traditional donor tissue-derived MSCs in potency, consistency, and regenerative potential.
Ada Torres
Ada Torres
5 Feb 2025
Macro Metals Limited has launched its second Indigenous joint venture, Robe River Kuruma Macro Mining, to foster sustainable mining and socio-economic benefits in the West Pilbara region.
Maxwell Dee
Maxwell Dee
5 Feb 2025
Dynamic Metals has secured approval to commence an extensive Reverse Circulation drilling campaign at its Cognac West gold prospect, targeting high-grade anomalies identified in recent sampling. The program, set to begin in early 2025, aims to unlock significant gold mineralisation in Western Australia’s Widgiemooltha region.
Maxwell Dee
Maxwell Dee
5 Feb 2025